1Bhatt DL,Steg PG,Ohman EM,et al.International prevalence,recognition,and treatment of cardiovascular risk factors in outpatients with atherothrombosis[J].JAMA,2006,295:180-189.
2Viles-Gonzalez JF,Fuster V,Badimon JJ.Atherothrombosis:a widespread disease with unpredictable and life-threatening consequences[J].Eur Heart J,2004,25:1197-1207.
4Broos K,Trekels M,Jose RA,et al.Identification of a small molecule that modulates platelet glycoprotein Ⅰb-von Willebrand factor interaction[J].J Biol Chem,2012,287:9461-9472.
5Auton M,Sowa KE,Behymer M,et al.N-terminal flanking region of A1 domain in yon Willebrand factor stabilizes structure of A1A2A3 complex and modulates platelet activation under shear stress[J].J Biol Chem,2012,287:14579-14585.
6Kalli AC,Campbell ID,Sansom MS.Multiscale simulations suggest a mechanism for integrin inside-out activation[J].Proc Natl Acad Sci U S A,2011,108:11890-11895.
7Singh HS,Dangas GD,Guagliumi G,et al.Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMItrial)[J].Am J Cardiol,2012,110:940-947.
8O'Brien KA,Gartner TK,Hay N,et al.ADP-stimulated activation of Akt during integrin outside-in signaling promotes platelet spreading by inhibiting glycogen synthase kinase-3β[J].Arterioscler Thromb Vasc Biol,2012,32:2232-2240.
2Jeffrey S. Berger,Maria C. Roncaglioni,Fausto Avanzini,Ierta Pangrazzi,Gianni Tognoni,David L. Brown,崔艳丽（译）,赵秀丽（校）.阿斯匹林在男性和女性心血管事件一级预防中的应用——随机对照试验性别特异性汇总分析[J].美国医学会杂志（中文版）,2006,25(5):275-282. 被引量：40
6Eric L Eisenstein, DBA,Kevin J. Anstrom, PhD,David F. Kong, MD,Linda K. Shaw, MS,Robert H. Tuttle, MSPH,Daniel B. Mark, MD, MPH,Judith M. Kramer, MD, MS,Robert A. Harrington, MD,David B. Matchar, MD,David E. Kandzari, MD 1,Eric D. Peterson, MD, MPH,Kevin A. Schulman, MD,Robert M. Califf, MD,李呈亿（译）,David E. Kandzari, MD.氯吡格雷的使用与药物洗脱支架植入后远期临床结果[J].美国医学会杂志（中文版）,2007,26(3):131-139. 被引量：59
